Supportivtherapie

Titel
Studie
Jahr

Antianemic Treatment of Cancer Patients in German Routine Practice: Data from a Prospective Cohort – The Tumor Anemia Registry.

Steinmetz, T., Schröder, J., Plath, M., Link, H., Vogt, M., Frank, M., Marschner, N., 2016.

Anemia 2016, e8057650. doi:10.1155/2016/8057650

Indikation: Supportivtherapie; Veranstaltung: -; Journal: Anemia

TAR
2016

Prevention and treatment of chemotherapy-induced neutropenia with the biosimilar filgrastim: a non-interventional observational study of clinical practice patterns.

Tesch, H., Ulshöfer, T., Vehling-Kaiser, U., Ottillinger, B., Bulenda, D., Turner, M., 2015.

Oncol Res Treat 38, 146–152. doi:10.1159/000381318

Indikation: Supportivtherapie; Veranstaltung: -; Journal: Oncology Research and Treatment

HEXAFIL
2015

Anti-anemic treatment of cancer patients in German routine practice – data from a prospective cohort study, the Tumor Anemia Registry (TAR).

Steinmetz, T., Schröder, J., Plath, M., Link, H., Vogt, M., Frank, M., Marschner, N., 2015.

Supportive Care in Cancer 23(Suppl. 1), 361. doi:10.1007/s00520-015-2712-y

Indikation: Supportivtherapie; Veranstaltung: MASCC; Journal: Supportive Care in Cancer

TAR
2015

Chemotherapy-induced nausea and vomiting – treatment and patient-reported outcomes in German outpatient cancer centres: Final data from the Emesis-Registry.

Schröder, J., Wiegand, J., Dörfel, S., Jähnich, S., Boller, E., Marschner, N., 2015.

Support Care Cancer 23(Suppl. 1), S139. doi:10.1007/s00520-015-2712-y

Indikation: Supportivtherapie; Veranstaltung: MASCC; Journal: Supportive Care in Cancer

Emesis-Register
2015

NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim – First Interim Analysis.

Kurbacher, C.M., Fietz, T., Diel, I.J., Egert, M., Hurtz, H.-J., Lück, A., Weide, R., Salat, C., Wolff, T., Zaiss, M., Klare, P., Losem, C., Illmer, T., Weißenborn, G., Steffens, C.-C., Schulze, M., Tesch, H., Oskay-Oezcelik, G., Teichmann, B., Harde, J., Scheuerlein, R.W., 2015.

Oncol Res Treat 38, 221–229. doi:10.1159/000381631

Indikation: Supportivtherapie; Veranstaltung: -; Journal: Oncology Research and Treatment

NADIR
2015

Antianämische Therapien bei Patientinnen mit Mammakarzinom: Daten aus dem Tumoranämie-Register.

Steinmetz, T., Schlag, R., Sandner, R., Semsek, D., Frank, M., Vogt, M., Jänicke, M., Marschner, N., 2014.

Senologie – Zeitschrift für Mammadiagnostik und -therapie (11). doi:10.1055/s-0034-1375492

Indikation: Supportivtherapie; Veranstaltung: Senologie Kongress; Journal: Senologie

TAR
2014

Effectiveness of treatments for tumor-(therapy-) associated anemia in routine practice – data from the clinical tumor anemia registry (TAR).

Steinmetz, T., Köhler, A., Groschek, M., Koenigsmann, M., Vogt, M., Frank, M., Jänicke, M., 2014.

Oncol ResTreat 37 (suppl 5)(P534), 172. doi:10.1159/000368945

Indikation: Supportivtherapie; Veranstaltung: DGHO; Journal: Oncology Research and Treatment

TAR
2014

Treatment of chemotherapy-induced neutropenia with Lipegfilgrastim (Lonquex®): First interim analysis of the non-interventional study NADIR.

Kurbacher, C., Diel, I., Egert, M., Fietz, T., Hurtz, H., Lück, A., Weide, R., Wolff, T., Zaiss, M., Teichmann, B., Harde, J., Scheuerlein, R., 2014.

Oncol Res Treat 37(suppl 5)(P512). doi:10.1159/000368945

Indikation: Supportivtherapie; Veranstaltung: DGHO; Journal: Oncology Research and Treatment

NADIR
2014

Routine treatment of anemia in cancer patients in Germany – data from the clinical registry on tumorassociated anemia (TAR Registry).

Steinmetz, H., Wierecky, J., Rauh, J., Selak, Vogt, M., Hartmann, H., Marschner, N., 2013.

Onkologie 36 (suppl 7)(V712), 212. doi:10.1159/000356365

Indikation: Supportivtherapie; Veranstaltung: DGHO; Journal: Onkologie

TAR
2013

Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia.

Steinmetz, T., Tschechne, B., Harlin, O., Klement, B., Franzem, M., Wamhoff, J., Tesch, H., Rohrberg, R., Marschner, N., 2013.

Ann Oncol 24, 475–482. doi:10.1093/annonc/mds338

Indikation: Supportivtherapie; Veranstaltung: -; Journal: Annals of Oncology

Ferinject-NIS
2013

Noninterventional study HEXAFIL: analysis of G-CSF-supported chemotherapy regimens.

Tesch, H., Indorf, M., Chang, D., Ottilinger, B., 2012.

Onkologie 35 (Suppl 6)(P236), 72. doi:10.1159/000170919

Indikation: Supportivtherapie; Veranstaltung: DGHO; Journal: Onkologie

HEXAFIL
2012

Routine treatment of anemia in cancer patients in Germany – data from the clinical registry on anemiatherapy (TAR Registry).

Steinmetz, T., Reichert, D., Zimber, J., Hartmann, H., Vogt, M., Marschner, N., 2012.

Onkologie 35 (suppl 6)(V838), 252. doi:10.1159/000178474

Indikation: Supportivtherapie; Veranstaltung: DGHO; Journal: Onkologie

TAR
2012

Intention of Treating Chemotherapy-Induced Neutropenia with Biosimilar Filgrastim and Change of Practice.

Tesch, H., Turner, M., Indorf, M., 2011.

SIOG Annual Meeting, Paris.

Indikation: Supportivtherapie; Veranstaltung: SIOG; Journal: -

HEXAFIL
2011

Analysis of the non-interventional study with Filgrastim-Hexal®: safety profile and patient perception.

Tesch, H., Indorf, M., Schmid, T., Rauh, J., Stoetzer, O., Schaller-Kranz, T., 2011

Onkologie 34 (suppl 6)(P867), 259. doi:10.1159/000333304

Indikation: Supportivtherapie; Veranstaltung: DGHO; Journal: Onkologie

HEXAFIL
2011

Supportive Treatment of Chemotherapy-Induced Neutropenia with Biosimilar Filgrastim: the HEXAFIL Non-Interventional Study.

Tesch, H., Indorf, M., Schaller-Kranz, T., 2011.

EMCC / ESMO (Poster 280, Abstract 4025), 308.

Indikation: Supportivtherapie; Veranstaltung: EMCC (ESMO); Journal: -

HEXAFIL
2011

Effectiveness and tolerability of ferric carboymaltose in the correction of cancer- and chemotherapy-associated anaemia – a multicenter observational study.

Steinmetz, T., Tschechne, B., Virgin, G., Klement, B., Rzychon, B., Franzem, M., Wamhoff, J., Tesch, H., Rohrberg, R., Marschner, N., 2011.

chemotherapy-associated anaemia – a multicenter observational study. EMCC / ESMO (Poster 294, Abstract 3000).

Indikation: Supportivtherapie; Veranstaltung: EMCC (ESMO); Journal: -

Ferinject-NIS
2011

Ferric Carboxymaltose for the Correction of Cancer- and Chemotherapy-Assiciated Anemia in Clinical Practice.

Steinmetz, T., Tschechne, B., Virgin, G., Klement, B., Franzem, M., Wamhoff, J., Tesch, H., Rohrberg, R., Marschner, N., 2011.

haematologica 96(s2), 0983.

Indikation: Supportivtherapie; Veranstaltung: EHA; Journal: Haematologica

Ferinject-NIS
2011

Treatment of cancer- and chemotherapy-associated anemia with ferric carboxymaltose in clinical practice.

Steinmetz, T., Tschechne, B., Harlin, O., Klement, B., Franzem, M., Wamhoff, J., Tech, H., Rohrberg, R., Marschner, N., 2011.

Onkologie 34 (suppl 6)(V1012), 304. doi:10.1159/000333303

Indikation: Supportivtherapie; Veranstaltung: DGHO; Journal: Onkologie

Ferinject-NIS
2011

HEXAFIL: Non-interventional study for supportive treatment of chemotherapy induced neutopenia with Filgrastim HEXAL®.

Tesch, H., Indorf, M., Hartmann, U., 2010.

Onkologie 33 (suppl 6)(P241), 71. doi:10.1159/000321409

Indikation: Supportivtherapie; Veranstaltung: DGHO; Journal: Onkologie

HEXAFIL
2010

Treatment of tumor induced iron deficiency with ferric carboxymaltose (FCM, ferinject®)

Steinmetz, T., Tschechne, B., Selak, E., Kellner, T., Schröder, D., Marschner, N., Virgin, G., Kaldeweier, A., 2010.

Onkologie 33 (suppl 6)(P250), 74. doi:10.1159/000321409

Indikation: Supportivtherapie; Veranstaltung: DGHO; Journal: Onkologie

Ferinject-NIS
2010

Epidemiological register of the image of antiemetic-strategies in the everyday routine.

Schröder, J., Boeckmann, W., Wiegand, J., Eggert, J., Jehner, P., Dörfel, S., Göhler, T., Jänich, S., 2009.

Onkologie 32 (suppl 4)(P524), 143. doi:10.1159/000242464

Indikation: Supportivtherapie; Veranstaltung: DGHO; Journal: Onkologie

Emesis-Register
2009

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com